Norethindrone Acetate in the Medical Management of Adenomyosis [PDF]
Pharmaceuticals, 2012 The role of norethindrone acetate (NA) in the management of adenomyosis was evaluated with a retrospective chart review of 28 premenopausal women between 27–49 years of age presenting with moderate to severe pelvic pain and bleeding.
Özgül Muneyyirci-Delale
exaly +8 more sources
Medical management of recurrent endometrioma with long-term norethindrone acetate [PDF]
International Journal of Women's Health, 2012 Ozgul Muneyyirci-Delale1,2, Jenny Anopa1, Cassandra Charles1, Deepali Mathur1, Rudolph Parris1, Jed B Cutler2, Ghadir Salame1,2, Ovadia Abulafia1,21Department of Obstetrics and Gynecology, SUNY Downstate Medical Center, New York, NY, USA; 2Department of ...
Muneyyirci-Delale O +7 more
doaj +7 more sources
Oral GnRH Antagonists in Combination with Estradiol and Norethindrone Acetate for Pain Relief Associated with Endometriosis: A Review of Evidence of a Novel Class of Hormonal Agents [PDF]
International Journal of Women's HealthEssam R Othman,1,2 Ayman Al-Hendy,3 Radwa Mostafa,1 Cornelis B Lambalk,2 Velja Mijatovic2 1OB-GYN Department, Assiut University, Assiut, 71515, Egypt; 2Academic Endometriosis Center, Amsterdam University Medical Center, Vrije Universiteit Amsterdam ...
Ayman Al-Hendy +2 more
exaly +5 more sources
Unilateral Erythema Nodosum following Norethindrone Acetate, Ethinyl Estradiol, and Ferrous Fumarate Combination Therapy [PDF]
Case Reports in Obstetrics and Gynecology, 2016 Erythema nodosum is a septal panniculitis that typically presents as symmetric, tender nodules on the anterior aspects of bilateral lower extremities.
Michelle S. Min +2 more
doaj +3 more sources
Suppression of an accessory and cavitated uterine mass with norethindrone: a case report [PDF]
F&S ReportsObjective: To describe conservative management for accessory and cavitated uterine mass (ACUM) with norethindrone acetate. The patient gave signed written, informed consent authorizing publication.
Hope Knochenhauer, M.D. +2 more
doaj +3 more sources
A Novel Intrauterine Device for the Spatio-Temporal Release of Norethindrone Acetate as a Counter-Estrogenic Intervention in the Genitourinary Syndrome of Menopause [PDF]
PharmaceuticsThe genitourinary syndrome of menopause (GSM) is a widely occurring condition affecting millions of women worldwide. The current treatment of GSM involves the use of orally or vaginally administered estrogens, often with the risk of endometrial ...
Ahmed Abdelgader +3 more
doaj +3 more sources
Evaluation of pharmacokinetic interactions between long‐acting cabotegravir or emtricitabine/tenofovir disoproxil fumarate and hormonal contraceptive agents: a tertiary analysis of South African participants in HPTN 084 [PDF]
Journal of the International AIDS SocietyIntroduction HPTN 084 found that long‐acting cabotegravir (CAB‐LA) was well‐tolerated and significantly reduced the risk of HIV acquisition in women compared to tenofovir disoproxil fumarate/emtricitabine (F/TDF).
Mark A. Marzinke +21 more
doaj +3 more sources
Norethindrone acetate or dienogest for the treatment of symptomatic endometriosis: a before and after study [PDF]
Fertility and Sterility, 2016 To assess the proportion of patients satisfied with their treatment before and after a systematic change from norethindrone acetate to dienogest as the first-line progestin for symptomatic endometriosis.Before and after study.Academic department.The last 90 new consecutive endometriosis patients in whom norethindrone acetate was used, and the first 90 ...
Paolo Vercellini +2 more
exaly +4 more sources
HT update: spotlight on estradiol/norethindrone acetate combination therapy
Clinical Interventions in Aging, 2008 Colleen L Casey, Christine A MurrayUniversity of Vermont, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Burlington, VT, USAAbstract: The goal of postmenopausal hormone therapy is to alleviate the ...
Colleen L Casey, Christine A Murray
doaj +5 more sources
The effect of low-dose combined hormone therapy (oestradiol and norethindrone acetate) on serum C-reactive protein levels and life quality in natural menopause women [PDF]
Menopause Review, 2021 Şal, Hidayet/0000-0002-3586-6125Introduction: To assess the effect of low-dose combined oestradiol and norethindrone acetate hormone therapy (HT) on serum C-reactive protein (CRP) levels and life quality in natural menopause women.
Servin Gocer +3 more
doaj +3 more sources